BBIO Greek Exposure
BBIO is BRIDGEBIO PHARMA, a Healthcare company with a $15.25B market cap. Gamma (GEX) highlights support/resistance from dealer hedging, Delta (DEX) shows bullish vs bearish bets, Vanna tracks volatility-driven flows, and Charm shows time-decay hedging. Analyze exposure by strike and expiration to find key price levels.
- Name
- BRIDGEBIO PHARMA
- Type
- Common Stock
- Sector
- Healthcare
- Market cap
- $15.25B
- Avg. daily volume (30d)
- 2.96M
- Next earnings
- 2027-02-23
Frequently asked questions
- What is BBIO gamma exposure (GEX)?
- Gamma exposure (GEX) measures how much market makers must hedge when BBIO stock moves. Positive GEX means dealers are long gamma and will hedge in a stabilizing way (buy dips, sell rallies), while negative GEX means their hedging amplifies moves.
- What is BBIO delta exposure (DEX)?
- Delta exposure (DEX) shows the net directional options exposure on BBIO. It represents how many shares market makers need to buy or sell to stay delta-neutral. Large DEX shifts can indicate significant directional positioning.
- How do BBIO Vanna and Charm affect the stock?
- Vanna measures how BBIO option deltas change with implied volatility — when IV drops, positive vanna exposure forces dealers to buy shares, creating upward pressure. Charm measures delta decay over time, causing similar hedging flows as options approach expiration.